Leukotrap WB System - CP2D
- Product NDC
- 87069-126
- 11-digit product format
- 870690126
- Labeler code
- 87069
- Product ID
- 87069-126_55b57873-3c3b-0ce2-e063-6294a90aa6ce
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- CP2D/AS-3 - Anticoagulant and Additive System
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Labeler
- GVS TM INC
- Application
- BN820915
- Marketing category
- NDA
- Marketing start
- 2025-11-28
- Substance
- DEXTROSE, UNSPECIFIED FORM
- Active strength
- 3.57 g/70mL
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Leukotrap WB System - CP2D
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DEXTROSE, UNSPECIFIED FORM | 3.57 g/70mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| IY9XDZ35W2 | Internal UNII lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 44a82ea8-69bf-f061-e063-6394a90af3da | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Leukotrap RC System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 4c0dec79-1648-1cfd-e063-6394a90a88cc | 2026-07-03 | BN820915 | |
| Leukotrap WB System - CP2D | CP2D/AS-3 - ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 44a82ea8-69bf-f061-e063-6394a90af3da | 2026-07-03 | BN820915 87069-126 | |
| Leukotrap WB system - CP2D | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 42ece7e1-1da1-7e5a-e063-6294a90ac803 | 2026-07-03 | BN820915 | |
| Leukotrap WB System - CP2D | CP2D/AS-3 - ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 44a7d200-13cb-c0b0-e063-6294a90aafad | 2026-07-03 | BN820915 87069-126 | |
| Leukotrap RC PL System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54eab581-bc48-f9f0-e063-6394a90a4b93 | 2026-06-25 | BN820915 | |
| Leukotrap WB system - CP2D | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54fdf3cf-41df-af7d-e063-6294a90ab1e6 | 2026-06-24 | BN820915 | |
| Blood Collection System | CP2D/AS-3 TRIPLE WITH SAMPLING SYSTEM | GVS TM INC | 54e8cfd2-f91b-8381-e063-6394a90a3f77 | 2026-06-23 | BN820915 | |
| Leukotrap RC PL System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54e9a497-7a94-44c9-e063-6294a90a84da | 2026-06-23 | BN820915 | |
| Leukotrap RC PL System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54eb0462-cd00-4467-e063-6394a90aa371 | 2026-06-23 | BN820915 | |
| Leukotrap RC System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54eb3c81-5cc8-03c4-e063-6294a90a2065 | 2026-06-23 | BN820915 | |
| Leukotrap RC System | CP2D/AS-3 ANTICOAGULANT AND ADDITIVE SYSTEM | GVS TM INC | 54ebb700-3bcf-d0e3-e063-6394a90a57c8 | 2026-06-23 | BN820915 | |
| AS-3 | AS-3 | GVS TM INC | 3dfa3397-fc13-4659-e063-6394a90a5abc | 2025-11-06 | Warnings | BN820915 |
| CP2D | CP2D | GVS TM INC | 3fa2e438-2ff0-a2df-e063-6394a90ac7b5 | 2025-11-06 | Warnings | BN820915 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 87069-126-62 | 87069012662 | 6 POUCH in 1 CARTON (87069-126-62) / 3 BAG in 1 POUCH / 70 mL in 1 BAG | 6 pouch | 2026-06-23 | No | No | Current |
| 87069-126-63 | 87069012663 | 6 POUCH in 1 CARTON (87069-126-63) / 3 BAG in 1 POUCH / 70 mL in 1 BAG | 6 pouch | 2025-11-28 | No | No | Current |